Guangzhou Innogen Pharmaceutical Group Co., Ltd (INNOGEN-B) aksje
2591.HK
HK$9.960-0.420 (-4.05%)
Laster graf...
INNOGEN-B
Market Cap
$4,549,920,768
Åpning10.570
Høy10.850
Lav9.820
Volum4.83M
P/EN/A
Markedsverdi4.55B
52-ukers høy74.000
52-ukers lav9.730
Gj.sn. volum3.11M
UtbytteN/A
BetaN/A
EPS-0.920
Om Guangzhou Innogen Pharmaceutical Group Co., Ltd (INNOGEN-B) aksje
Guangzhou Innogen Pharmaceutical Group Co., Ltd engages in the development of drug engaged in the research, development and commercialization of pharmaceutical products. The company's products are used for the treatment of metabolic diseases, including diabetes, obesity and overweight, and MASH; and other major central nervous system diseases. The company was incorporated in 2014 and is based in Shanghai, China.
Selskapsinformasjon
Børs: HKSE (HKG)
Sektor: Sundhed
Industri: Bioteknologi
Adresse:
Qiantan Times Square
Shanghai, China
Shanghai, China
Nettside: https://www.innogenpharm.com
Analytikernes aksjeanbefalinger
Denne oversikten gir et raskt innblikk i hvordan analytikere vurderer aksjens potensial basert på deres siste analyser og kursmål.
Laveste kursmål
28.25
↑ 183.6%
Gjennomsnittlig kursmål
31.71
↑ 218.4%
Median kursmål
31.71
↑ 218.4%
Høyeste kursmål
35.17
↑ 253.1%